Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends
- PMID: 33595784
- DOI: 10.1007/s12010-021-03521-z
Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends
Abstract
Urinary tract infection (UTI), a prevalent disease in India, also ranks among the most common infections in developing countries. The rapid emergence of antibiotic-resistant uropathogenic Escherichia coli (UPECs), the leading etiologic agent of UTI, in the last few years, led to an upsurge in the health care cost. This caused a considerable economic burden, especially in low-middle income country, India. This review aimed to provide an explicit overview of the recent advancements in E. coli-mediated UTI in India by incorporation of valuable information from the works published in PubMed and Google Scholar in the last six years (2015 to August, 2020). The literature survey demonstrated UPECs as the most predominant uropathogen in India, especially among females, causing both asymptomatic bacteriuria (ABU) and symptomatic UTI. An overall increasing national trend in resistance to penicillins, cephalosporins, aminoglycosides, fluoroquinolones, and sulfonamides was perceived irrespective of ABU and symptomatic UPECs during the aforementioned study period. High incidences of multidrug resistance, extended-spectrum β-lactamases, metallo β-lactamases, and AmpCs in UPECs were reported. Notable information on the pathogenic profiles, phylogroups, pathogenicity islands, and evidence of pathoadaptive FimH mutations was described. Alternative therapeutics and potential drug targets against UPECs were also reconnoitered. Therefore, the nationwide widespread occurrences of highly virulent MDR UPEC together with the limited availability of therapeutics highlighted the urgent need for promotion and invention of alternative therapeutics, search for which had already been started. Moreover, investigation of several mechanisms of UPEC infection and the search for potential drug targets might help to design newer therapeutics.
Keywords: Alternative therapeutics; India; Urinary tract infection, multidrug resistance; Uropathogenic Escherichia coli.
References
-
- Karigoudar, R. M., Karigoudar, M. H., Wavare, S. M., & Mangalgi, S. S. (2019). Detection of biofilm among uropathogenic Escherichia coli and its correlation with antibiotic resistance pattern. Journal of Laboratory Physicians, 11 [01], 017-022.
-
- Ghosh, A., & Mukherjee, M. (2019). Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients. Folia Microbiologica, 64(4), 587-600
-
- Paralikar, P., Ingle, A.P., Tiwari, V., Golinska, P., Dahm, H., & Rai, M. (2019). Evaluation of antibacterial efficacy of sulfur nanoparticles alone and in combination with antibiotics against multidrug-resistant uropathogenic bacteria. Journal of Environmental Science and Health, Part A, 54[5], 381-390.
-
- Gopichand, P., Agarwal, G., Natarajan, M., Mandal, J., Deepanjali, S., Parameswaran, S., & Dorairajan, L.N. (2019). In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections. Infection and Drug Resistance, Volume 12, 2005-2013.
-
- Malik, S., Sidhu, P.K., Rana, J.S., & Nehra, K. (2019). Managing urinary tract infections through phage therapy: a novel approach. Folia Microbiologica, 65[2], 217-231.
Publication types
MeSH terms
Substances
Grants and funding
- EMR/2016/001670 dated 22.08.17/Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India
- 62(Sanc.)/BT/P/Budget/RD-60/2017 dated 12.03.2018/Department of Higher Education, Science & Technology and Biotechnology, Government of West Bengal, India
- DST/INSPIRE Fellowship/2016/ IF160069 (2016-2019)/INSPIRE fellowship grant from Department of Science &Technology, New Delhi, Government of India
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
